The Broader Spectrum: Liquid Biopsy's Role Beyond Cancer in Molecular Diagnostics
While oncology dominates the current market landscape, accounting for well over $85\%$ of the liquid biopsy application segment, the technology's long-term growth is set to be fueled by its expansion into a much broader range of clinical applications. The fundamental principle—analyzing circulating biomarkers in bodily fluids—is not exclusive to cancer and holds immense promise for...
0 Σχόλια 0 Μοιράστηκε 304 Views 0 Προεπισκόπηση